NCT02152007View on ClinicalTrials.gov

Topical Sirolimus for the Treatment of Pachyonychia Congenita (PC)

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

November 30, 2015

Conditions
Pachyonychia Congenita
Interventions
DRUG

1% sirolimus cream (TD201 1%)

1% sirolimus cream (TD201 1%)

Trial Locations (1)

94305

Stanford University, Stanford

All Listed Sponsors
collaborator

Pachyonychia Congenita Project

OTHER

lead

TransDerm, Inc.

INDUSTRY

NCT02152007 - Topical Sirolimus for the Treatment of Pachyonychia Congenita (PC) | Biotech Hunter | Biotech Hunter